Tennessee will receive more than $1.2 billion in opioid settlement funds. Experts fear the money isn’t reaching people who need it the most.

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress ...